Which of the following cholinomimetics is commonly used in the treatment of glaucoma?

Questions 52

ATI RN

ATI RN Test Bank

Pharmacology of Cardiovascular Drugs Questions

Question 1 of 5

Which of the following cholinomimetics is commonly used in the treatment of glaucoma?

Correct Answer: A

Rationale: In the treatment of glaucoma, the commonly used cholinomimetic is Pilocarpine (Option A). Pilocarpine is a direct-acting cholinergic agonist that acts on muscarinic receptors in the eye, specifically the ciliary muscle, leading to miosis and increased outflow of aqueous humor, thereby reducing intraocular pressure. Lobeline (Option B) is not used in the treatment of glaucoma. It is a respiratory stimulant and has no direct effect on intraocular pressure. Acetylcholine (Option C) is rapidly broken down by acetylcholinesterase and therefore not used clinically due to its short duration of action. Neostigmine (Option D) is an indirect-acting cholinomimetic that inhibits acetylcholinesterase, leading to an increase in acetylcholine levels. It is used in conditions like myasthenia gravis but not for glaucoma. Understanding the pharmacology of cholinomimetics in the context of glaucoma is crucial for healthcare professionals to make informed decisions in the management of this condition. Pilocarpine's mechanism of action and clinical application highlight its importance in the treatment of elevated intraocular pressure associated with glaucoma, making it the appropriate choice among the options provided.

Question 2 of 5

Indicate the beta1-selective agonist:

Correct Answer: B

Rationale: In the context of pharmacology, understanding the difference between various cardiovascular drugs is crucial for safe and effective patient care. In this question, the correct answer is option B) Dobutamine, a beta1-selective agonist. Dobutamine is a synthetic catecholamine that primarily stimulates beta1-adrenergic receptors in the heart. By selectively targeting beta1 receptors, it increases cardiac contractility and output without significant effects on beta2 receptors found in the lungs, which helps to avoid potential bronchoconstriction. Now, let's discuss why the other options are incorrect: A) Isoproterenol: Isoproterenol is a non-selective beta agonist, meaning it stimulates both beta1 and beta2 receptors, leading to potential side effects like tachycardia and bronchodilation. C) Metaproterenol: Metaproterenol is a non-selective beta agonist similar to isoproterenol, affecting both beta1 and beta2 receptors. D) Epinephrine: Epinephrine is a non-selective adrenergic agonist that acts on both alpha and beta receptors, causing a wide range of effects including increased heart rate, vasoconstriction, and bronchodilation. Understanding the selectivity of beta agonists is crucial in pharmacology to tailor drug therapy to achieve desired effects while minimizing adverse reactions. In clinical practice, selecting the appropriate beta agonist based on receptor selectivity can significantly impact patient outcomes and safety.

Question 3 of 5

Compared with phentolamine prazosin has all of the following features EXCEPT:

Correct Answer: A

Rationale: In the context of pharmacology of cardiovascular drugs, understanding the key differences between phentolamine and prazosin is crucial for effective clinical application. The correct answer, A) Irreversible blockade of alpha receptors, is right because phentolamine is an alpha receptor antagonist that exerts reversible blockade, unlike prazosin which is reversible. This difference is important for managing potential adverse effects and determining the duration of action. Option B) Highly selective for alpha1 receptors is incorrect because prazosin is actually less selective for alpha1 receptors compared to other alpha blockers. This lack of selectivity can lead to a wider range of effects, including potential side effects. Option C) The relative absence of tachycardia is incorrect for prazosin as it is associated with a higher incidence of reflex tachycardia compared to phentolamine due to its alpha1 receptor blockade. Understanding these differences helps in predicting and managing cardiovascular responses to these drugs. Option D) Persistent block of alpha1 receptors is incorrect because prazosin has a shorter duration of action compared to phentolamine due to its reversible nature. This difference is important in dosing regimens and frequency of administration in clinical practice. Educationally, grasping these distinctions enhances pharmacological knowledge, aids in rational drug selection, and promotes safe and effective medication management in cardiovascular conditions. Understanding the nuances of drug actions can improve therapeutic outcomes and reduce the risk of adverse effects, highlighting the importance of precise pharmacological knowledge in clinical practice.

Question 4 of 5

Which of the following hypnotic agents is able to interact with both BZ1 and BZ2 receptor subtypes?

Correct Answer: C

Rationale: In pharmacology, understanding the specific receptor interactions of drugs is crucial for predicting their effects. In this case, the correct answer is C) Flurazepam. Flurazepam is a hypnotic agent that can interact with both BZ1 and BZ2 receptor subtypes. This is important because BZ1 receptors are involved in the sedative effects of benzodiazepines, while BZ2 receptors are involved in the anxiolytic effects. By interacting with both receptor subtypes, Flurazepam can produce a combination of sedative and anxiolytic effects, making it an effective hypnotic agent. Now, let's look at why the other options are incorrect: A) Zaleplon primarily acts on the BZ1 receptor subtype. B) Phenobarbital is a barbiturate that acts through GABA receptors, not benzodiazepine receptors. D) Zolpidem mainly targets the BZ1 receptor subtype, not both BZ1 and BZ2. Understanding the specific receptor interactions of drugs not only helps in selecting the most appropriate medication for a given condition but also aids in predicting potential side effects and drug interactions. This knowledge is essential for healthcare professionals to make informed decisions when prescribing medications to patients with cardiovascular issues or other conditions requiring pharmacological intervention.

Question 5 of 5

The drug of choice in the treatment of petit mal (absence seizures) is:

Correct Answer: B

Rationale: In the treatment of petit mal (absence seizures), the drug of choice is Ethosuximide (Option B). Ethosuximide specifically targets and controls absence seizures by blocking T-type calcium channels in the thalamic neurons, which are implicated in the generation of these types of seizures. This mechanism of action makes it more effective for petit mal seizures compared to the other options. Phenytoin (Option A) is more commonly used for tonic-clonic and focal seizures, not absence seizures. Phenobarbital (Option C) is more effective for generalized tonic-clonic and partial seizures, not absence seizures. Carbamazepine (Option D) is primarily used for focal seizures and trigeminal neuralgia, not absence seizures. In an educational context, understanding the specific mechanisms of action and indications for each anti-seizure medication is crucial for pharmacology students and healthcare professionals to make informed decisions when selecting the appropriate drug for a patient's condition. This knowledge ensures safe and effective treatment interventions, highlighting the importance of accurate drug selection based on the type of seizure disorder being treated.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions